Adam J Gormley

age ~41

from Plainfield, NJ

Get Report

Also known as:

Connected to:

Adam Gormley Phones & Addresses

Gold Particles And Methods Of Making And Using The Same In Cancer Treatment
view source
US Patent:

20130177523, Jul 11, 2013
Filed:

Jul 13, 2011
Appl. No.:

13/809595
Inventors:

Hamid Ghandehari - Salt Lake City UT, US
Adam Gormley - Salt Lake City UT, US
Abhijit Ray - Salt Lake City UT, US
Nate Larson - Murray UT, US
Assignee:

University of Utah Research Foundation - Salt Lake City UT
International Classification:

A61K 41/00
A61N 5/06
C08G 65/48
US Classification:

424 7827, 530330, 556113, 514 218, 4351731, 5253303, 525 542, 525 541, 428401, 428402, 604501
Abstract:

Described herein are gold particles that can be used to reduce tumor proliferation and treat cancer. In certain aspects, the gold particles can be modified in order to enhance selectivity and uptake of the particles by cancer cells. In certain aspects, the modified gold particles have a targeting group attached to the particle via a linker. The gold particles described herein can be used in combination with other anti-cancer agents in order to enhance overall cancer treatment. Methods for making and using the gold particles are also described herein.

Vivo Radical-Mediated Polymerization For Targeted Delivery Of Trophic Factors
view source
US Patent:

20210369864, Dec 2, 2021
Filed:

Aug 10, 2021
Appl. No.:

17/398606
Inventors:

- New Brunswick NJ, US
David I. Shreiber - Whitehouse Station NJ, US
Emily DiMartini - Brick Township NJ, US
Adam Gormley - New Brunswick NJ, US
Assignee:

Rutgers, The State University of New Jersey - New Brunswick NJ
International Classification:

A61K 47/69
A61K 47/34
A61K 47/10
C08L 33/06
Abstract:

The present invention provides a biocompatible conjugate for treating a disease or an injury. The conjugate contains a polymer covalently linked to one or more moieties each containing a polymerizable functional group. The conjugate forms a cross-linked polymer network after being exposed to an elevated level of free radicals associated with the disease or injury.

In Vivo Radical-Mediated Polymerization For Targeted Delivery Of Trophic Factors
view source
US Patent:

20180360989, Dec 20, 2018
Filed:

Jun 14, 2018
Appl. No.:

16/009033
Inventors:

- New Brunswick NJ, US
David I. Shreiber - Whitehouse Station NJ, US
Emily DiMartini - Piscataway NJ, US
Adam Gormley - New Brunswick NJ, US
Assignee:

Rutgers, The State University of New Jersey - New Brunswick NJ
International Classification:

A61K 47/69
A61K 47/34
A61K 47/10
C08L 33/06
A61K 47/32
Abstract:

The present invention provides a biocompatible conjugate for treating a disease or an injury. The conjugate contains a polymer covalently linked to one or more moieties each containing a polymerizable functional group. The conjugate forms a cross-linked polymer network after being exposed to an elevated level of free radicals associated with the disease or injury.